Centaurus Financial’s Avanos Medical AVNS Stock Holding History

Centaurus Financial’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-21	Closed	-$1K	–	639
2018 Q2	$1K	Buy	+21	New	+$1.11K	﹤0.01%	2065

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Centaurus Financial's AVNS Position: Q3 2018 in Review

Centaurus Financial sold out of Avanos Medical (AVNS) in Q3 2018, closing a stake of 21 shares — an estimated $1K sold.

Centaurus Financial first reported a position in AVNS in Q2 2018 and held it in 1 quarter. The position peaked at $1K in Q2 2018. 387 funds tracked by Wall St. Rank hold AVNS as of Q3 2018.

Centaurus Financial reported no remaining Avanos Medical position as of Q3 2018 after selling out during the quarter.
Centaurus Financial sold 21 Avanos Medical shares in Q3 2018, an estimated $1K.
Centaurus Financial first reported a position in Avanos Medical in Q2 2018 and held it in 1 quarter.
Centaurus Financial's Avanos Medical position peaked at $1K in Q2 2018.
387 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2018.

Based on Centaurus Financial's 13F filing for Q3 2018, filed 5 Nov 2018.